BSE Live
Apr 10, 16:01Prev. Close
730.05
Open Price
738.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 10, 15:50Prev. Close
725.80
Open Price
736.70
Bid Price (Qty.)
732.00 (97)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Albert David (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | |
| Total Share Capital | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | |
| Reserves and Surplus | 87.11 | 84.63 | 75.40 | 69.85 | 65.20 | |
| Total Reserves and Surplus | 87.11 | 84.63 | 75.40 | 69.85 | 65.20 | |
| Total Shareholders Funds | 92.82 | 90.34 | 81.11 | 75.55 | 70.91 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 6.00 | 11.96 | 8.02 | 3.24 | 9.22 | |
| Deferred Tax Liabilities [Net] | 0.00 | 3.69 | 4.50 | 3.73 | 3.87 | |
| Other Long Term Liabilities | 4.16 | 3.45 | 3.33 | 10.35 | 11.95 | |
| Long Term Provisions | 6.49 | 6.61 | 31.13 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 16.66 | 25.71 | 46.99 | 17.31 | 25.04 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 22.10 | 27.89 | 29.77 | 33.68 | 31.83 | |
| Trade Payables | 30.47 | 30.35 | 36.76 | 31.11 | 23.00 | |
| Other Current Liabilities | 20.30 | 16.32 | 6.13 | 12.37 | 10.60 | |
| Short Term Provisions | 11.10 | 7.39 | 8.85 | 32.80 | 35.60 | |
| Total Current Liabilities | 83.97 | 81.95 | 81.50 | 109.97 | 101.03 | |
| Total Capital And Liabilities | 193.45 | 198.00 | 209.59 | 202.83 | 196.98 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 49.46 | 67.42 | 71.88 | 69.43 | 68.95 | |
| Intangible Assets | 0.02 | 0.03 | 0.04 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 5.04 | 2.60 | 1.34 | 6.03 | 2.97 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 54.52 | 70.06 | 73.26 | 75.46 | 71.92 | |
| Non-Current Investments | 16.50 | 16.50 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 2.71 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 3.37 | 3.43 | 26.33 | 10.99 | 10.25 | |
| Other Non-Current Assets | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | |
| Total Non-Current Assets | 77.10 | 89.99 | 99.60 | 86.45 | 82.17 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 52.14 | 43.12 | 42.56 | 40.25 | 34.70 | |
| Trade Receivables | 41.08 | 42.59 | 36.97 | 29.76 | 19.42 | |
| Cash And Cash Equivalents | 9.98 | 9.26 | 14.53 | 11.52 | 23.64 | |
| Short Term Loans And Advances | 12.76 | 12.65 | 15.54 | 34.04 | 36.28 | |
| OtherCurrentAssets | 0.39 | 0.39 | 0.39 | 0.82 | 0.78 | |
| Total Current Assets | 116.35 | 108.01 | 109.99 | 116.38 | 114.80 | |
| Total Assets | 193.45 | 198.00 | 209.59 | 202.83 | 196.98 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 47.32 | 46.43 | 13.15 | 15.35 | 11.36 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 35.38 | 28.42 | 27.31 | 26.51 | 20.91 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.41 | 0.57 | 0.00 | 0.00 | 0.76 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 1.51 | 1.03 | 1.36 | 1.11 | 1.70 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 31.45 | 28.54 | 22.61 | 20.85 | 17.50 | |
| Other Earnings | 1.49 | 1.59 | 1.05 | 1.12 | 1.15 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 16.50 | 16.50 | 0.00 | 0.00 | 0.00 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
25.02.2026
Albert David Standalone December 2025 Net Sales at Rs 89.93 crore, up 8.24% Y-o-Y
13.11.2025
Albert David Standalone September 2025 Net Sales at Rs 87.24 crore, down 11.37% Y-o-Y
05.08.2025
Albert David Standalone June 2025 Net Sales at Rs 70.57 crore, down 21.03% Y-o-Y
13.05.2025
Albert David Standalone March 2025 Net Sales at Rs 74.89 crore, down 15.9% Y-o-Y
10.04.2026
09.04.2026
08.04.2026
Indian CDMOs face tariff exposure via patented drug supply chains
08.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth